Biology Reference
In-Depth Information
17. Perry SJ, Baillie GS, Kohout TA, et al. Targeting of cyclic AMP degradation to beta
2-adrenergic receptors by beta-arrestins. Science . 2002;298:834 - 836.
18. Nelson CD, Perry SJ, Regier DS, Prescott SM, TophamMK, Lefkowitz RJ. Targeting
of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. Science .
2007;315:663- 666.
19. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ. Beta-arrestin inhibits
NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor
IkappaBalpha. Proc Natl Acad Sci USA . 2004;101:8603 - 8607.
20. Bhattacharya M, Anborgh PH, Babwah AV, et al. Beta-arrestins regulate a Ral-GDS
Ral effector pathway that mediates cytoskeletal
reorganization. Nat Cell Biol .
2002;4:547 - 555.
21. Zoudilova M, Kumar P, Ge L, Wang P, Bokoch GM, DeFea KA. Beta-
arrestin-dependent regulation of the cofilin pathway downstream of protease-activated
receptor-2. J Biol Chem . 2007;282:20634 - 20646.
22. Beaulieu JM, Sotnikova TD, Yao WD, et al. Lithium antagonizes dopamine-
dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cas-
cade. Proc Natl Acad Sci USA . 2004;101:5099 - 5104.
23. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG.
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotrans-
mission and behavior. Cell . 2005;122:261 - 273.
24. Gesty-Palmer D, Luttrell LM. Refining efficacy: exploiting functional selectivity for
drug discovery. Adv Pharmacol . 2011;62:79 - 107.
25. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM. b Α rrestin scaffolding of
the ERK cascade enhances cytosolic ERK activity but inhibits ERK mediated tran-
scription following
angiotensin AT1a
receptor
stimulation.
J Biol Chem .
2002;277:9429 - 9436.
26. Burack WR, Shaw AS. Signal transduction: hanging on a scaffold. Curr Opin Cell Biol .
2000;12:211 - 216.
27. Elion EA. The Ste5p scaffold. J Cell Sci . 2001;114:3967 - 3978.
28. Scott MG, Le Rouzic E, Perianin A, et al. Differential nucleocytoplasmic shuttling of
beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2.
J Biol Chem . 2002;277:37693- 37701.
29. Wang P, Wu Y, Ge X, Ma L, Pei G. Subcellular localization of beta-arrestins is deter-
mined by their intact N domain and the nuclear export signal at the C terminus. J Biol
Chem . 2003;278:11648 - 11653.
30. Breitman M, Kook S, Gimenez LE, et al. Silent scaffolds: inhibition of c-Jun
N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. J Biol
Chem . 2012;287:19653 - 19664.
31. Tohgo A, Choy EW, Gesty-Palmer D, et al. The stability of the G protein-coupled
receptor-beta-arrestin interaction determines the mechanism and functional conse-
quence of ERK activation. J Biol Chem . 2003;278:6258 - 6267.
32. Wei H, Ahn S, Shenoy SK, et al. Independent G protein and beta-Arrestin2 medi-
ated activation of ERK by angiotensin. Proc Natl Acad Sci USA . 2003;100:
10782 - 10787.
33. Kendall RT, Luttrell LM. Diversity in
b -Arrestin Function. Cell Mol Life Sci .
2009;66:2953- 2973.
34. Ahn S, Shenoy SK, Wei H, Lefkowitz RJ. Differential kinetic and spatial patterns of
beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.
J Biol Chem . 2004;279:35518- 35525.
35. DeWire SM, Kim J, Whalen EJ, Ahn S, Chen M, Lefkowitz RJ. Beta-
arrestin-mediated signaling regulates protein synthesis.
J Biol Chem . 2008;283:
10611 - 10620.
 
 
 
Search WWH ::




Custom Search